Bullen Alexander L, Fregoso Alma, Ascher Simon B, Shlipak Michael G, Ix Joachim H, Rifkin Dena E
Nephrology Section, Veterans Affairs San Diego Healthcare System, La Jolla, California, USA.
Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, California, USA.
Nephron. 2023;147(12):713-716. doi: 10.1159/000531946. Epub 2023 Jul 31.
Serum creatinine and albuminuria are primary markers of glomerular function and injury, respectively. Tubular secretion, acid-base homeostasis, protein reabsorption, among other tubular functions, are largely ignored. This mini-review aimed to discuss how two tubular functions, secretion, and acid-base homeostasis are associated with major adverse kidney events (MAKEs).
Proximal tubular secretion is an essential function that allows the elimination of endogenous substances and drugs. Recently discovered endogenous markers in urine and plasma allow a noninvasive way of assessing tubular secretion markers. Several studies have found an association between these markers and a higher risk of chronic kidney disease (CKD) progression and mortality. In a study we recently performed among patients with CKD and at risk of cardiovascular events, lower tubular secretion was associated with an increased risk of acute kidney injury and metabolic acidosis, independent of baseline eGFR and albuminuria. The kidney tubules also play a crucial role in acid-base homeostasis. Although the standard clinical assessment of acidosis consists of measuring serum bicarbonate, urinary ammonium excretion decreases before over metabolic acidosis. Urinary ammonium excretion is associated with CKD progression, a higher risk of kidney failure, and an increased mortality risk, independent of baseline eGFR and albuminuria.
Novel biomarkers of kidney tubular health consistently associate with MAKEs, above and beyond baseline eGFR, albuminuria, and other CKD risk factors. Tubular markers may provide new opportunities to improve kidney prognosis, drug dosing, and monitoring for adverse events.
血清肌酐和蛋白尿分别是肾小球功能和损伤的主要标志物。肾小管分泌、酸碱平衡、蛋白质重吸收等肾小管功能在很大程度上被忽视了。本综述旨在探讨肾小管的两种功能——分泌和酸碱平衡——如何与主要不良肾脏事件(MAKEs)相关联。
近端肾小管分泌是一项重要功能,可清除内源性物质和药物。最近在尿液和血浆中发现的内源性标志物为评估肾小管分泌标志物提供了一种非侵入性方法。多项研究发现,这些标志物与慢性肾脏病(CKD)进展及死亡风险较高有关。在我们最近对有心血管事件风险的CKD患者进行的一项研究中,肾小管分泌降低与急性肾损伤和代谢性酸中毒风险增加相关,且独立于基线估算肾小球滤过率(eGFR)和蛋白尿。肾小管在酸碱平衡中也起着关键作用。虽然酸中毒的标准临床评估包括测量血清碳酸氢盐,但在代谢性酸中毒发生之前尿铵排泄就会减少。尿铵排泄与CKD进展、肾衰竭风险较高及死亡风险增加相关,且独立于基线eGFR和蛋白尿。
肾小管健康的新型生物标志物始终与MAKEs相关,超出了基线eGFR、蛋白尿和其他CKD风险因素。肾小管标志物可能为改善肾脏预后、药物剂量调整及不良事件监测提供新机会。